Company begins roll out of innovative diabetes care HbA1c column system in Brazil Commercial leadership strengthened with key appointment DUBLIN, March 12, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc ...
GLTR ETF review: transparent gold, silver, platinum & palladium exposure; diversification vs. equities, plus tax/volatility drawbacks and DBP comparison. Read more macro analysis here.
Company begins roll out of innovative diabetes care HbA1c column system in Brazil Commercial leadership strengthened with key appointmentDUBLIN, ...
Jazz Pharmaceuticals PLC (JAZZ) reports a robust Q4 with $1.2 billion in revenue, driven by strong performances across key products and strategic launches.
Dialog Axiata PLC, Sri Lanka’s #1 connectivity provider, announced the introduction of the Oscal Tiger 8 5G, further expanding access to next-generation mobile connectivity across the country.
As of Friday, February 27, NIQ Global Intelligence plc’s NIQ share price has surged by 6.36%, which has investors questioning if this is right time to sell.
I know it can be irritating to be asked to subscribe to get additional information – especially when you've relied on Moneyweb's free data for years. But the cost of sourcing th ...
EET Certain financial information of Easor Plc 1 Jan. to 31 Dec. 2025 (unaudited): The foundation has now been laid - focus on growth The implementation ...
Financial Results. TORM (NASDAQ: TRMD) (NASDAQ: TRMD A) performed well in 2025 with the fourth quarter seeing further positive momentum, demonstrating the agility and resilience o ...
The approval enables it to work directly with airport teams during the rollout of its automated ground support equipment.
Good morning, everyone, and welcome to IMI's 2025 Full Year Results Presentation. I am joined here today by our CFO, Luke Grant. Together, we will take you through another year of strong strategic and ...
The Company’s presence at ATTD follows compelling clinical performance data from its latest CGM technology developments, which formed the basis for Trinity Biotech’s decision to advance the program ...